Issue |
BIO Web Conf.
Volume 100, 2024
International Scientific Forum “Modern Trends in Sustainable Development of Biological Sciences” (IFBioScFU 2024)
|
|
---|---|---|
Article Number | 02004 | |
Number of page(s) | 6 | |
Section | Current Issues in Biotechnology, Microbiology, and Bioengineering | |
DOI | https://doi.org/10.1051/bioconf/202410002004 | |
Published online | 08 April 2024 |
Evaluation of phage cocktail efficacy for controlling infections caused by pathogenic Escherichia coli in in vivo experiments
Research and Production Center for Microbiology and Virology, Almaty, 050010, Kazakhstan
* Corresponding author: madina.a06@gmail.com
Colibacillosis is a common veterinary infection that causes huge economic losses to the livestock and poultry industry. Uncontrolled use of antibiotics has led to the emergence and spread of multidrug resistant bacteria and has reduced the effectiveness of standard treatment regimens for infectious diseases. This stimulated the renewed interest in bacteriophages among scientists since the beginning of the 21st century. Bacteriophages are widespread in nature and accompany bacteria in every environment they colonize, including the microbiota of warm-blooded animals. The purpose of the research was to study the therapeutic activity of a cocktail created on the basis of bacteriophages isolated in the territory of the Republic of Kazakhstan. The therapeutic activity of the phage cocktail was determined through experimental infection of chickens with a pathogenic strain of E. coli. The in vivo experiments showed that the administration of the bacteriophage cocktail enabled 86% of the chickens to survive after being infected with lethal doses of pathogenic E. coli. They also revealed that the frequency of phage cocktail administration did not affect its efficacy. Thus, the investigated phage cocktail is a promising candidate for the creation of biotechnological antibacterial agents on its basis for safe and effective treatment of poultry against colibacillosis.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.